Translating Neuroprediction Into Precision Medicine Via Brain Priming

NCT03370510 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Covid-19 Pandemic

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Oxytocin
BEHAVIORAL: Pivotal Response Treatment
DRUG: Placebo

Sponsor

Yale University